Medicon Valley (Denmark & Sweden) Biotech Day at MassBio

Tuesday, September 14 2010
11:45 am – 4:00 pm

Event Inquiries

MassBio, communications@massbio.org

Location: MassBio

NOTE: Only MassBio members can register online here. If you are not a MassBio member, but would like to participate, email joamik@um.dk.

Jointly presented by Copenhagen Capacity, Invest in Skåne, and MassBio

 

Join us for the Medicon Valley Day at MassBio on September 14th.

The event meeting will focus on facilitating close ties between the Medicon Valley region and the Massachusetts Super Cluster and will include a presentation of technologies of visiting Medicon Vally companies, as well as opportunities to partner.

Expected participating Medicon Valley companies:

Alligator BioScience, Anoto, BioInvent, Genovis, INAGEN, Symphogen, Novo Nordisk, Zealand Pharma, Inventure Capital, MC2 Biotek, Neurosearch, LK Biosciences, Nycomed, Tectra, Novozymes.

The Medicon Valley Day at MassBio offers keynotes and presentations on leading medical innovation and commercialization strategies and therapeutic focus areas among researchers in the Medicon Valley region of Denwmark and Sweden, including  antibodies; neurosciences; cancer; diabetes and metabolic diseases; inflammation, allergy and autoimmune diseases; infectious diseases; IVD and medical devices.

Featured keynote addresses by Dr. Hans Lilga, Lund University and Memorial Sloan-Kettering Cancer Center and Dr. Marie Skovgaard of Zealand Pharma, and Bruce Pratt, V.P. for Science Development at Genzyme Corporation.

For more information about Medicon Valley, visit www.mediconvalley.com.

This event will be held at MassBio, One Cambridge Center, Cambridge, MA 02142.

 

AGENDA

11:45   - 12:00        Registration

12:00-1:00 PM          Welcome Remarks and Luncheon

featuring "Life Sciences in the Medicon Valley"

Presentation by Copenhagen Capacity / Invest in Skåne

1:05 – 1:35 p.m. Dr. Hand Lilja, Lund University and Memorial Sloan-Kettering Cancer Center.

"Cancer Research - A Cross-regional Perspective"

1:35 – 2:00 p.m.          Refreshment Break

2:00 – 2:30 p.m.         Dr. Marie Skovgaard, Head of Medicinal Chemistry, Zealand Pharma

"Biotech in the Medicon Valley - The Zealand Pharma Story"

2:30 – 2:45 p.m.          Bruce Pratt, Vice President for Science Development, Genzyme Corporation

"Global Partnerships: The Genzyme Perspective"

3:00-4:30 p.m. Medicon Valley Science & Technology Opportuinities

Panel presentations by Medicon Valley participants.

4:30 p.m.           Closing

MassBio

 

 

 

Collaboratives

 

 

Med Device